Colchicine and Kisqali drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colchicine (colchicine) and Kisqali (ribociclib succinate). Common drug interactions include movement disorder among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Colchicine and Kisqali. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Colchicine?

Colchicine has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 21,826 Colchicine users. Check the latest studies of Colchicine.

What is Kisqali?

Kisqali has active ingredients of ribociclib succinate. eHealthMe is studying from 25,049 Kisqali users. Check the latest studies of Kisqali.

On Jul, 09, 2026

12 people who take Colchicine and Kisqali together, and have interactions are studied.

Colchicine and Kisqali drug interactions.

What are the common drug interactions of Colchicine and Kisqali, by gender? *:

female:

Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Myocarditis (inflammation of heart muscle myocardium)
Malaise (a feeling of general discomfort or uneasiness)
Drug ineffective
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Neoplasm progression (growth of tumour)
Abdominal discomfort
Agitation (state of anxiety or nervous excitement)
Cardiomegaly (increased size of heart than normal)
Fatigue (feeling of tiredness)

male:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Thrombosis (formation of a blood clot inside a blood vessel)

What are the common drug interactions of Colchicine and Kisqali, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Agitation (state of anxiety or nervous excitement)
Cardiomegaly (increased size of heart than normal)
Diarrhoea
Infection
Limb discomfort (discomfort in leg)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Pain
Pericardial effusion (fluid around the heart)
Peripheral swelling
Pleural disorder

50-59:

n/a

60+:

Chest pain
Diarrhoea
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Drug ineffective
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Neoplasm progression (growth of tumour)
Headache (pain in head)
Heart rate increased
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Breast Cancer Metastatic: 8 people, 66.67%
Metastases To Bone (cancer spreads to bone): 2 people, 16.67%
Breast Cancer Male: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Colchicine and Kisqali?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously